5 Top Tips for Stability: How to Build Inspection‑Ready, Scientifically Robust Programmes
Article By Vicki Pike, EPiC Operations Manager
Ensuring the stability of medicinal products is one of the most important responsibilities for any pharmaceutical manufacturer. Stability issues remain a leading cause of product recalls, and regulators expect companies to maintain scientifically sound, well‑controlled, and well‑documented stability programmes.
Drawing on best practices reflected in regulatory guidelines and our own internal expertise, here are our Top 5 Tips on Stability that will strengthen compliance, reduce risk, and enhance product lifecycle management.
Best practices for Stability
1. Anchor Your Stability Programme in ICH Q1
A compliant, defensible stability strategy starts with the ICH Q1 series (Q1A–F*), which remains the global benchmark for stability expectations.
Key actions:
- Conduct stress testing (thermal, humidity, photostability) early to understand degradation pathways.
- Define specifications per ICH Q6, including physical, chemical and microbiological attributes.
- Use long‑term, intermediate and accelerated conditions matched to your climatic zone strategy.
- Ensure your stability protocol clearly defines pack types, timepoints, test methods and acceptance criteria.
*An updated and consolidated ICH Q1 Guideline has undergone public consultation and is pending sign off and adoption.
2. Strengthen Stability Operations with Real‑World Control
A well written protocol is not enough, regulators expect disciplined execution.
Essential controls:
- Perform stability pulls on time, within tightly controlled sampling windows.
- Maintain traceable sample management (receipt, storage, movement, destruction).
- Map and continually monitor stability chambers to ensure controlled, compliant conditions.
- Complete trend analysis at each timepoint to spot emerging concerns early.
- Prepare clear interim or annual stability summaries for ongoing product oversight.
3. Use Bracketing & Matrixing Wisely and Only When Justified
Bracketing and matrixing can reduce testing burden but regulators expect strong scientific justification.
Bracketing
Tests extremes across all timepoints (e.g., highest/lowest strength or largest/smallest pack size). Valid only when extremes represent the full design space.
Matrixing
Rotates the subset of samples tested at each interval.Must not mix storage conditions or test attributes across matrixing plans.
4. Treat Stability OOS or Atypical Trends as High‑Priority
Stability failures often signal a genuine risk to patient safety and product shelf‑life , treat them with urgency.
MHRA expectations for OOS/OOT include:
- Complete Phase Ia/Ib laboratory investigations, checking calculations, method validity, equipment failure or analyst errors.
- Move to Phase II when lab error is ruled out. Assess manufacturing history, raw materials, CPPs, environment, packaging, and storage/transport conditions.
- Evaluate potential impact on marketed batches and regulatory reporting requirements.
- Document clear CAPAs linked to a robust root cause narrative.
5. Investigate Root Causes Systematically with a Multidisciplinary Team
When stability issues arise, structured root cause analysis (RCA) is vital. A cross functional team should rigorously assess all possible contributors. A holistic, evidence based investigation ensures accurate conclusions and effective CAPA.
Here are some examples of potential causes of stability failures:
- API variability: potency or impurity levels at extremes of specification, changes to route of synthesis.
- Excipient or packaging changes: material variability or supplier changes.
- Manufacturing issues: dispensing errors, excess hold times, cross contamination, adverse environmental conditions.
- Packaging issues: packaging integrity failure.
- Storage conditions: temperature excursions during storage or transport.
Final Thoughts
Stability is a cornerstone of pharmaceutical quality and patient safety. By embedding strong scientific principles, disciplined operational practices, intelligent study design, high‑rigour investigations, and robust root‑cause analysis, companies can demonstrate full control of product quality throughout the lifecycle.
If you want stability studies that are scientifically justified, inspection‑ready, and executed with confidence, EPiC is ready to help. Let’s work together to strengthen your stability programme and safeguard your products, your patients, and your regulatory reputation.